Summary.-The cytotoxic effects in vivo of single doses of either adriamycin (ADM), 1-p -D-arabinofuranosylcytosine (Ara-C), bleomycin (BLM), cis-diamminedichloroplatinum (II) (cis-DDP), or cyclophosphamide (CY) on murine fibrosarcoma (FSa) cell populations were determined. Tumour cells were separated and synchronized by centrifugal elutriation. Viable tumour cells from selected elutriator fractions were then injected i.v. into whole-body-irradiated mice. Twenty minutes later selected doses of ADM, Ara-C, BLM, cis-DDP or CY were administered to selected groups of these animals. Fourteen days later the mice were killed. Killing of injected tumour cells by each of the chemotherapeutic agents was evidenced by a reduction in the lung colonies per cell injected in treated animals. Under these conditions the response of FSa cells in vivo to the 5 drugs tested differed both qualitatively and quantitatively. Ara-C was S-phase-specific in toxicity. ADM, BLM, and cis-DDP were preferentially toxic to S, G2+M and G1 cells respectively. CY, a drug requiring bioactivation to form alkylating metabolites, was found to be equally toxic to G1 and G2 + M enriched populations, but less effective in killing cell populations enriched with early-S cells.
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KNOWLEDGE of the differential cytotoxicity of drugs to cells in various phases of the cell cycle is extremely important to the design of chemotherapy protocols. Such studies have most frequently been carried out in vitro, using cultured cell lines. While this approach has given rise to information, many difficulties exist in relating these data to the complex in vivo situation (Valeriote & van Putten, 1975) . In vivo studies have been made, but they generally involve the use of two or more cytotoxic agents. A partial synchrony of "target" cells is induced by first exposing the host animal to a known phase-specific agent such as hydroxyurea (Madoc-Jones & Mauro, 1970) . At varying times afterwards, a second agent is administered and its effects are monitored. The difficulty with this approach, however, is in discerning whether the response of the cells to the second agent is perturbed in any way by exposure to the first.
In a recent communication we described a procedure for testing in vivo the phasespecific cytotoxicity of chemotherapeutic agents (Grdina et al., 1979) . The method is based on the separation and synchronization of tumour cells by centrifugal elutriation (Grdina et al., 1978a) . Cells enriched in the various phases of the cell cycle (i.e. the "target" populations) are injected i.v. into mice. At selected times later, the drug to be tested is administered either i.v., i.p. or s.c. With appropriate controls, the number of lung colonies formed reflects the phase-specific cytotoxicity of the test agent. This procedure is advantageous in that it is applicable to testing drugs which require bioactivation. Additionally, relatively large numbers of cells can be separated, synchronized and recovered without loss of viability.
In this communication we describe the cytotoxic effects of adriamycin (ADM), 1-P-D-arabinofuranosylcytosine (Ara-C), bleomycin (BLM), cis-diamminedichloroplatinum (II) (cis-DDP) and cyclophosphamide (CY) on synchronized murine fibrosarcoma (FSa) cells lodged in the lungs of specific-pathogen-free C3Hf/Kam mice. The tumour cells were separated by centrifugal elutriation and characterized with respect to cell-stage distribution by flow microfluorometry (FMF).
MATERIALS AND METHODS
Preparation of tumour cells. The tumour and cell-separation systems have been described in detail elsewhere (Grdina et al., 1979) . Briefly, tumour-source material was derived from 6th generation isotransplants of a methylcholanthrene-induced murine fibrosarcoma (Suit & Suchato, 1967) . Ten-twelveweek-old female C3Hf/Kam mice from our specific-pathogen-free breeding colony were used. Single-cell suspensions were obtained by mincing and trypsinization (Grdina et al., 1975) . Cell viability was determined by phasecontrast microscopy and was routinely > 9500. Tumour cells derived in this manner were then incubated in vitro for 48 h before centrifugal elutriation to improve synchrony (Grdina et al., 1978a) .
Cell separation by centrifugal elutriation.-Tumour cells were separated under sterile conditions using a Beckman JE-6 elutriator rotor (Grdina et al., 1978a) . The rotor chamber and associated tubing were sterilized by pumping 70% ethanol throughout the system. The ethanol was allowed to remain in the system overnight. Before use, ethanol was removed and sterile Solution A (8-0 g NaCl, 0 4 g KCI, 1 0 g glucose, and 0 35 g NaHCO3 in 1 1 H20) was used to rinse out the system.
The separation medium consisted of modified
McCoy's 5A (Humphrey et al., 1970) Co., St Louis, MO) at a final concentration of 0 1 mg/ml and 5mM 2-naphthol 6-8 disulphonic acid to reduce cell clumping (Shortman, 1973) . All separations were performed at 4°C. During separation the rotor speed was set at 1525 rev/min and the flow rates were varied by equal increments from 5-4 to 27-4 ml/min. Routinely, 2 x 108 cells were separated. Twelve fractions were collected and then stored at 4°C. Cells collected in each fraction were counted by haemacytometer and by Coulter counter (model ZBI; Coulter Electronics, Hialeah, FL), and their volume distributions determined with a multichannel analyser (Channelyzer II; Coulter Electronics). The modal volume was designated as the volume corresponding to the modal channel number of the volume distribution of each sample (Grdina et al., 1978a) . The DNA content of individual cells in suspension was determined by flow microfluorometry (FMF) using an ICP II flow cytometer (Phywe Co., Gottingen, Germany). Cells were stained with mithramycin (Grdina et al., 1978a) and the resultant histograms of DNA fluorescence were computer analysed (Johnston et al., 1978) .
Lung colony assay.-The colony-forming efficiency (CFE) of FSa cells was determined by a lung colony assay (Hill & Bush, 1969) .
To maximize CFE, recipient mice, with their hind legs shielded, were whole-body irradiated with 10 Gy 24 h before use. These mice were injected with 1-5 x 104 viable FSa cells from each of the elutriator fractions, or an unseparated control population (USC) along with 2 x 106 heavily irradiated (HIR; 100 Gy) FSa tumour cells. The HIR cells were not separated by centrifugal elutriation. Fourteen days later the mice were killed, their lungs removed, the lobes separated and fixed in Bouin's solution, and tumour colonies counted. (Grdina et al., 1978b) . Drug doses and routes of administration were chosen which allowed for sufficient expression of tumour cell killing but minimized toxic effects to the animals used in the experiments.
RESULTS
A variety of chemotherapeutic agents have been tested in vivo against murine fibrosarcoma cell populations synchronized by centrifugal elutriation. Presented in Fig. 1 is a representative sedimentation profile, describing the relationship between modal cell volume and the number of cells recovered in each elutriator fraction. Cell recovery ranged from 85 to 95%.
Cell viability, as determined by phasecontrast microscopy, was routinely > 95% for cells collected in Fractions (F) 3-11. Fl and F2 were discarded because they contained subcellular debris and damaged cells. F12 and F13 contained mixtures of large and small cells, as well as small clumps of cells washed out of the rotor at the end of the run; these fractions were therefore also discarded. Using the method of flow microfluorometry, no non-tumour cells were detected in any of the fractions. These cells had been eliminated from the tumour population by incubating the tumour suspension for 48 h in vitro before separation (Grdina et al., 1978a) . The colony-forming efficiency (CFE) of untreated cell populations varied between experiments from 1 to 3% (i.e. an average of 50-150 colonies per animal). Within each experiment, however, no appreciable difference in CFE was observed between the elutriated control groups. All experiments were repeated at least 3 times, and representative data are presented in each of the figures.
The cytotoxic effectiveness of ADM was tested in vivo on an unseparated control (USC) population and elutriator-synchronized FSa populations lodged in the lungs of test animals. For comparison, the drug was administered either i.p. at 5 mg/kg or i.v. at 10 mg/kg. Under either condition, cell killing was seen in all cell fractions, with the greatest reduction in CFE for cells collected in F9 (see Fig. 2 ). This elutriator fraction contained 80% S-phase cells.
For comparison, the CFE after exposure in vivo to ADM, Ara-C, BLM and cis- however, requires biotransformation by microsomal mixed-function oxidases to exert its cytotoxic effect (Brock & Hohorst, 1967) . In addition, phenobarbital has been found to accelerate the biotransformation of CY to its active form (Donelli et al., 1976; Peters & Mason, 1977) . The cytotoxic effect of CY on FSa cells lodged in the lungs of phenobarbital- 
DISCUSSION
In an earlier report we described in detail a procedure by which chemotherapeutic agents could be characterized in vivo with respect to phase specificity in cell killing (Grdina et al., 1979) . In particular, we chose hydroxyurea for initial investigation, because it had been well characterized with respect to its phasespecific toxicity to S cells. We (Kim & Kim, 1972) . Our results agree with these findings. ADM cytotoxicity in vivo, as evidenced by a reduction in the number of lung colonies in treated mice, was greatest for FSa cell populations most enriched with S cells (see Fig. 2 ). This effect, though differing in magnitude, was similar for the two doses and routes of injection used. Ara-C is a known S-specific agent (Skipper et al., 1967; Momparler, 1974) . As shown in Fig. 3 , cell killing correlated well with the percentage of S cells in each fraction. BLM, an agent reported to be most effective against G2 and M cells (Barranco & Humphrey, 1971; Drewinko & Barlogie, 1976 ) was found to be most toxic to G2+M FSa cells collected in F10 and Fl l.
Cis-DDP was included in this study because it has been demonstrated under in vitro conditions to be preferentially cytotoxic to G1 (Drewinko et al., 1973; Fraval & Roberts, 1979) . As shown in Fig. 3 , cis-DDP was most toxic to the G1-enriched FSa population in F3. In a recent report, centrifugal elutriation was used to separate and synchronize Chinese hamster ovary (CHO) cells in order to characterize the cycle-dependent cytotoxicity of selected chemotherapeutic agents in vitro (Meyn et al., 1980) . CHO cells were observed in this study to be most sensitive to cis-DDP in G1, ADM and Ara-C in 5, and BLM in G2 +M.
There is excellent agreement between data derived from established in vitro methods and those presented here concerning the cytotoxic activities of ADM, Ara-C, BLM and cis-DDP. These agents have been demonstrated to exert similar cell-cycle phase-dependent toxicity under both in vitro and in vivo conditions. The in vivo method has the advantage that it permits the direct characterization of agents which require bioactivation to become effective. For this reason, cyclophosphamide was chosen for study. CY is a potent antineoplastic agent which must be metabolized, primarily by microsomal enzymes in the liver, to produce alkylating metabolites (Brock & Hohorst, 1967) . To accelerate this effect, liver microsomal enzymes can be stimulated by phenobarbital (Donelli et al., 1976; Peters & Mason, 1977) . Alkylating agents are known to be more toxic to G1 and M cells than to S cells (Bhuyan, 1977) . Results presented in Fig. 4 indicate that FSa populations enriched with S cells (i.e. F6 and F7) were less sensitive to CY toxicity than cells from the other fractions. These results were confirmed in 3 separate experiments.
In conclusion, we have characterized in vivo the cell-cycle phase-specific effects of a variety of chemotherapeutic agents currently used in the treatment of malignant disease. The method described in this communication can also be applied to include the separation and synchronization of FSa cells grown as pulmonary nodules in mice, without the requirement of a preseparation incubation in vitro (Grdina, 1980) . Data acquired in this manner, however, must be interpreted with respect to the pharmacological properties of the agents tested and the animal system used. Chemotherapeutic agents can thus be routinely and rapidly evaluated under in vivo conditions with respect to their phase-specificity in cell killing, effect on cell kinetics, and toxicity to the host animal.
